2021
DOI: 10.2217/bmm-2020-0691
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers of Cholestasis

Abstract: Cholestasis is a major pathological manifestation, often resulting in detrimental liver conditions, which occurs in a variety of indications collectively termed cholestatic liver diseases. The frequent asymptomatic character and complexity of cholestasis, together with the lack of a straightforward biomarker, hampers early detection and treatment of the condition. The ‘omics’ era, however, has resulted in a plethora of cholestatic indicators, yet a single, clinically applicable biomarker for a given cholestati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(6 citation statements)
references
References 144 publications
(210 reference statements)
0
6
0
Order By: Relevance
“…Moreover, a significant absolute increase in total glycine-conjugated BA was evident in female NAFLD. The secondary BA were not significantly different to controls, but higher total primary BA may indicate a gender-dependent disposition to cholestasis [ 22 ]. Accordingly [ 23 ], the female controls had lower median levels of total primary BA compared to male controls.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, a significant absolute increase in total glycine-conjugated BA was evident in female NAFLD. The secondary BA were not significantly different to controls, but higher total primary BA may indicate a gender-dependent disposition to cholestasis [ 22 ]. Accordingly [ 23 ], the female controls had lower median levels of total primary BA compared to male controls.…”
Section: Discussionmentioning
confidence: 99%
“…Table 2 summarizes specific hereditary cholestatic liver diseases and the genes with causative mutations. 15 However, mutations in individual genes account for only a small portion of liver diseases, and most hereditary liver diseases are caused by mutations of multiple genes or a combination of gene mutations and environmental factors.…”
Section: Molecular Markersmentioning
confidence: 99%
“…Serum γ-glutamyltransferase (GGT) is a trypsin widely distributed on the surface of glandular and ductal epithelial cells, mainly secreted by the liver, and it is also the most sensitive liver enzyme to reflect biliary obstruction and liver injury [9]. Studies have shown that GGT has a certain correlation with the prognosis and survival of various digestive tract malignancies, but due to a variety of other diseases and conditions (such as renal insufficiency, diabetes, pancreatitis, myocardial infarction, obesity and alcohol intake) Serum GGT levels are elevated and therefore lack specificity [9][10][11].…”
Section: Introductionmentioning
confidence: 99%